default author photo

Peter G. Kremsner

Lambaréné Medical Research Center (CERMEL), Lambaréné

SCHOLARLY PAPERS

4

DOWNLOADS

1,716

TOTAL CITATIONS

10

Scholarly Papers (4)

1.

Efficacy and Safety of the CVnCoV SARS-CoV-2 mRNA Vaccine Candidate: Results from Herald, a Phase 2b/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America

Number of pages: 29 Posted: 27 Aug 2021
Lambaréné Medical Research Center (CERMEL), Lambaréné, Corporacion Medica de General San Martin, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Universidad Simón Bolívar (USB) - Clínica de la Costa, Utrecht University - Julius Center for Health Sciences and Primary Care, Cevaxin, Instituto de Investigaciones Clinicas de Mar del Plata, Cohezio, Instituto de Investigación Nutricional, University of Tübingen - Institute of Tropical Medicine, Unidad de Medicina Especializada, Clinica Medica San Martin, Centro de Atención e Investigación Médica (CAIMED), Hospital Zonal General de Agudos Descentralizado Evita Pueblo de Berazategui, Lambaréné Medical Research Center (CERMEL), LambarénéUniversity of Amsterdam - Amsterdam Institute for Infection and Immunity, Clinical Research Institute Quilmes (Instituto de Investigaciones Clínicas Quilmes), CureVac AG, CureVac AG, Instituto de Investigación Nutricional, University of Cologne - Division of Infectious Diseases, Ghent University - Center for Vaccinology (CEVAC), CureVac AG, TecSalud - School of Medicine and Health Sciences, Universidad Peruana Cayetano Heredia - Instituto de Medicina Tropical Alexander von Humboldt, Sanatorio Parque S.A. Rosario, PanAmerican Clinical Research, Hospital Universitario Maternidad Nuestra Señora de La Altagracia - Fundacion Dominicana de Perinatologia PRO-BEBE, Inc., PanAmerican Clinical Research, Hospital del Niño Dr. José Renán Esquivel, Cogitars GmbH, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Centro de estudios en Infectologia Pediatrica (CEIP), Biodonostia Health Research Institute - Primary Care Group, P95 Pharmacovigilance and Epidemiology Services, Instituto de Investigaciones Clínicas Zárate, CureVac AG and Independent
Downloads 1,572 (29,255)
Citation 9

Abstract:

Loading...

CVnCoV mRNA vaccine; SARS-CoV-2; COVID-19; adults; randomised clinical trial

2.

Efficacy and Safety of Ivermectin for the Treatment of Plasmodium Falciparum Infections in Asymptomatic Gabonese Adults – A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Number of pages: 23 Posted: 15 Mar 2023
Lambaréné Medical Research Center (CERMEL), Lambaréné, Lambaréné Medical Research Center (CERMEL), Lambaréné, University of Tübingen, Lambaréné Medical Research Center (CERMEL), Lambaréné, Lambaréné Medical Research Center (CERMEL), Lambaréné, Lambaréné Medical Research Center (CERMEL), Lambaréné, Lambaréné Medical Research Center (CERMEL), Lambaréné, University of Tübingen - Institute of Tropical Medicine, University of Tübingen - Institute of Tropical Medicine, Lambaréné Medical Research Center (CERMEL), Lambaréné, Lambaréné Medical Research Center (CERMEL), Lambaréné, Lambaréné Medical Research Center (CERMEL), Lambaréné, University of Tübingen - Institute of Tropical Medicine, Lambaréné Medical Research Center (CERMEL), Lambaréné, Lambaréné Medical Research Center (CERMEL), Lambaréné, University of Hamburg - University Medical Center Hamburg-Eppendorf and Lambaréné Medical Research Center (CERMEL), Lambaréné
Downloads 73 (852,604)

Abstract:

Loading...

Ivermectin, Plasmodium falciparum, Blood stages, In vitro activity, In vivo efficacy, Dose-escalation, Randomized, Double-blind, safety, Adverse events, Parasite reduction, Transmission, Antiparasitic effect, Lambaréné, Gabon, Parasite load reduction, Tolerability, Mosquitocidal effect

3.

Is Large-Scale Rapid CoV-2 Testing a Substitute for Lockdowns?

Number of pages: 44 Posted: 26 Aug 2021
Johannes Gutenberg University Mainz, University of Hamburg, Lambaréné Medical Research Center (CERMEL), Lambaréné, University of Southern Denmark, University of Tübingen - Department of Economics, University of Tübingen - Faculty of Economics and Social Sciences, Johannes Gutenberg University Mainz and Johannes Gutenberg University Mainz - Gutenberg School of Economics and Management
Downloads 55 (1,010,164)
Citation 1

Abstract:

Loading...

4.

Microbially Acquired Lactose Tolerance Compensates for Host Genetic Lactase Deficiency across Continents

Number of pages: 68 Posted: 03 May 2026
Max Planck Institute for Biology Tübingen, Max Planck Institute for Biology Tübingen, Max Planck Institute for Biology Tübingen, Max Planck Institute for Biology Tübingen, Max Planck Institute for Biology Tübingen, Max Planck Institute for Biology Tübingen, Max Planck Institute for Biology Tübingen, Max Planck Institute for Biology Tübingen, Max Planck Institute for Biology Tübingen, Vietnamese-German Center for Medical Research, Sanford Burnham Prebys Medical Discovery Institute, Sanford Burnham Prebys Medical Discovery Institute, University of Copenhagen, University of Copenhagen, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen - Institute of Tropical Medicine, Vietnamese-German Center for Medical Research, Sanford Burnham Prebys Medical Discovery Institute, Lambaréné Medical Research Center (CERMEL), Lambaréné, Max Planck Institute for Biology Tübingen and Independent
Downloads 16 (1,500,778)

Abstract:

Loading...

Gut microbiome, microbial-induced lactose tolerance, lactose intolerance, lactase non-persistence, diet, hydrogen sulfide, methane, gas exhalation, lactulose